MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-19-0039102
Vivanta Diagnostic Private Limited
Vivanta Diagnostic Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.29 Cr
▲ 34% YoY
Net profit · FY 2025
₹6.81 Lakh
Net margin 3%
EBITDA · FY 2025
₹13.6 Lakh
EBITDA margin 5.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Vivanta Diagnostic Private Limited
Data last updated:
Vivanta Diagnostic Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 23 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2020PTC350555.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Humayun Tajuddin Shaikh and Aftabalam Mohd Yunus Sayyed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cst No 15F Hissa No 2 Chincholi Bundar Road Near Chandraraj Bldg Malad – West, Mumbai, Maharashtra, India – 400064.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.29 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹6.81 Lakh (net margin 3%) and EBITDA of ₹13.6 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
Vivanta Diagnostic Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0039102).
Company details
CIN U85300MH2020PTC350555
Registration Number 350555
Incorporation Date 23 November 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0039102
Key People
Humayun Tajuddin Shaikh Director Aftabalam Mohd Yunus Sayyed Director Eram Humayun Shaikh Director Recognitions & Rankings of Vivanta Diagnostic
Contact details
Vivanta Diagnostic Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressCst No 15F Hissa No 2 Chincholi Bundar Road Near Chandraraj Bldg Malad – West, Mumbai, Maharashtra, India – 400064
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Vivanta Diagnostic Private Limited, buy the company report.
Comprehensive company report
Vivanta Diagnostic Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vivanta Diagnostic is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Vivanta Diagnostic Private Limited, buy the company report.
Financials of Vivanta Diagnostic Private Limited
FY 2025 filings availableVivanta Diagnostic Private Limited reported revenue of ₹2.29 Cr (up 34% YoY) for FY 2025.
Revenue · FY 2025
₹2.29 Cr ▲ 34%
Net profit · FY 2025
₹6.81 Lakh margin 3%
EBITDA · FY 2025
₹13.6 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▼ 8%
Revenue has grown at a compounded annual rate (CAGR) of 10% over three years, including 34% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vivanta Diagnostic Private Limited, buy the company report.
Board of directors of Vivanta Diagnostic Private Limited
Vivanta Diagnostic has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Humayun Tajuddin Shaikh | Director | 23 Nov 2020 | 5 Years 11 Months | Current |
| Aftabalam Mohd Yunus Sayyed | Director | 23 Nov 2020 | 5 Years 11 Months | Current |
| Eram Humayun Shaikh | Director | 23 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Vivanta Diagnostic Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Impulse Diagnostics Centre Private Limited | ₹2.31 Cr (FY 2024) | 27.0% | Pune, Maharashtra, India | |||
| Vivanta Diagnostic Private Limitedthis company | ₹2.29 Cr (FY 2025) | ₹6.81 Lakh | 3% | 34.0% | Mumbai, Maharashtra, India | |
| Pathcore Molecular Labs Private Limited | ₹2.29 Cr (FY 2025) | 29.0% | Gurugram, Haryana, India | |||
| Bodycare Diagnostic Centre Pvt. Ltd. | ₹2.29 Cr (FY 2025) | -5.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Vivanta Diagnostic Private Limited, buy the company report.
Auditor
Vivanta Diagnostic Private Limited is audited by VADSARIA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VADSARIA & ASSOCIATES | FY 2023 | 164636 |
Shareholding
The shareholding of Vivanta Diagnostic Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Vivanta Diagnostic Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vivanta Diagnostic Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vivanta Diagnostic Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vivanta Diagnostic Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Vivanta Diagnostic Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vivanta Diagnostic Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Aftabalam Mohd Yunus Sayyed was appointed as Director on 23 Nov 2020.
AGM
Vivanta Diagnostic Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vivanta Diagnostic Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Aftabalam Mohd Yunus Sayyed was appointed as Director.
Appointed
Eram Humayun Shaikh was appointed as Director.
Appointed
Humayun Tajuddin Shaikh was appointed as Director.
Incorporation
23 Nov 2020
Vivanta Diagnostic Private Limited was registered on 23 Nov 2020 with Roc Mumbai & aged 5 years 11 months as per MCA records.
Frequently asked questions
Vivanta Diagnostic is an active private limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 23 November 2020 (6+ years old) and is registered under CIN U85300MH2020PTC350555.
Vivanta Diagnostic has 3 current directors:
- Humayun Tajuddin Shaikh - Director
- Aftabalam Mohd Yunus Sayyed - Director
- Eram Humayun Shaikh - Director
The latest financial statements of Vivanta Diagnostic on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Vivanta Diagnostic is U85300MH2020PTC350555. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vivanta Diagnostic was incorporated on 23 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vivanta Diagnostic by revenue are Impulse Diagnostics Centre Private Limited, Pathcore Molecular Labs Private Limited, Bodycare Diagnostic Centre Pvt. Ltd, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities).
Aftabalam Mohd Yunus Sayyed was appointed as Director on 23 Nov 2020. Eram Humayun Shaikh was appointed as Director on 23 Nov 2020. Humayun Tajuddin Shaikh was appointed as Director on 23 Nov 2020.
Yes, Vivanta Diagnostic is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0039102).
The registered office of Vivanta Diagnostic is at Cst No 15F Hissa No 2 Chincholi Bundar Road Near Chandraraj Bldg Malad – West, Mumbai, Maharashtra, India – 400064.
Vivanta Diagnostic operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Vivanta Diagnostic can be reached at its registered office: Cst No 15F Hissa No 2 Chincholi Bundar Road Near Chandraraj Bldg Malad – West, Mumbai, Maharashtra, India – 400064.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages